Sphinx’s mission is to accelerate the pace of biotech research by empowering scientific teams to make better decisions, faster. We are in the midst of a biological + computational renaissance with recent ground-breaking advancements in designing proteins from scratch, predicting protein structure, extracting insights from scientific literature. This research has the opportunity to revolutionize healthcare and biomanufacturing — but scientists are held back by the current tangled mess of spreadsheets, notebooks, and slide decks.
Sphinx provides a solution for biotech companies: a data platform for modern biotech companies to manage and analyze their data. We are the home for collaboration across laboratory scientists, computational biologists, and ML teams. In the future, all scientific experiments will be ML-driven, rigorously tracked, and fully automatable — and we’ll see scientific productivity skyrocket.
Join us to build that future.
We are backed by world-class investors including Benchmark Capital (investors in companies such as Uber, Twitter, Discord, Airtable, Confluent, Elastic).